Americans May Work 60 Years as Lifespans Hit 100

U.S. demographic trends are entering a phase that will materially influence labor markets, public finances and corporate strategy for decades. MarketWatch's May 9, 2026 feature highlights a scenario where improvements in longevity make living to 100 a realistic outcome for a substantial share of newborns and where working careers could extend to as long as 60 years (MarketWatch, May 9, 2026). The U.S. Census Bureau projected in 2018 that by 2034 the population aged 65 and older will outnumber those under 18, a watershed that will concentrate fiscal and private-sector attention on older cohorts (U.S. Census Bureau, 2018). Median age has already shifted: the 2020 Census reported a U.S. median age of 38.8, up from 37.2 in 2010, reflecting an ageing population and lower fertility trends (U.S. Census, 2020). For institutional investors, the question is not whether ageing will matter but how quickly markets and balance sheets will adjust to longer lives, later retirements and shifted consumption patterns.

Context

The demographic shift toward older populations has been gradual but persistent, driven by declining fertility and rising longevity. The U.S. Census Bureau's projection that adults 65+ will surpass children under 18 by 2034 is driven by baby-boomer aging and sustained improvements in survival at older ages (U.S. Census Bureau, 2018). These structural changes affect not only government programs—Social Security and Medicare—but also private-sector demand for housing, healthcare, financial products and workplace accommodations. Importantly, longevity gains are uneven across socioeconomic groups, which will amplify distributional stresses on public and private pensions and influence savings patterns.

Demography is policy-relevant because it alters both the numerator and denominator of fiscal sustainability metrics: beneficiaries and taxpayers. A longer-lived cohort increases lifetime healthcare and pension liabilities; a smaller working-age base compresses tax receipts per beneficiary unless offset by higher participation rates or immigration. The MarketWatch piece (May 9, 2026) frames an extreme-but-plausible scenario—working lives lengthening to 60 years—as a useful stress-test for existing retirement and labor-market institutions. Whether through delayed retirement, phased work, or increased productivity, the labour force must adjust if public finances are to remain sustainable without substantial tax changes or cuts to benefits.

The timing of adjustments is critical. Past demographic shifts—such as the retirement of baby boomers—played out over decades, allowing gradual policy and market responses. If longevity improvements accelerate, the required recalibrations for insurers, pension funds and employers will be more abrupt. Institutional investors should treat demographic signals as multi-decade drivers of asset allocation, corporate strategy and sovereign solvency, while recognizing significant cross-sectional differences by state, income and health status.

Data Deep Dive

Three concrete data points frame the discussion. First, MarketWatch (May 9, 2026) highlights actuarial work that suggests a materially higher chance of reaching centenarian status for children born today; some studies cited in the article place the probability as high as roughly one-in-three in developed countries. Second, the U.S. Census Bureau's 2018 projection that 65+ will outnumber under-18s by 2034 is a discrete date investors can use for scenario analysis (U.S. Census Bureau, 2018). Third, the 2020 Census reported a median U.S. age of 38.8, up from 37.2 in 2010, underscoring the ongoing trend toward an older population (U.S. Census, 2020).

Comparisons across time and geography sharpen the picture. The median age increase from 2010 to 2020 (1.6 years) contrasts with earlier decades when the median was comparatively younger following the post-war baby boom. Internationally, nations such as Japan and Italy are several years ahead on the ageing curve; their experience in long-term care financing, labor-market participation among older workers and pension reforms offers empirical benchmarks. Investors can compare projected dependency ratios—the number of dependents per working-age adult—across U.S. states to identify fiscal stress points and pockets of growth in age-related services.

Data limitations and measurement uncertainty must be acknowledged. Longevity projections rely on assumptions about medical innovation, chronic disease prevalence, and socioeconomic gradients. The same MarketWatch article aggregates several studies rather than a single consensus projection; accordingly, scenario work should bracket outcomes (e.g., high-, medium-, low-longevity scenarios) and be updated as registries and actuarial tables evolve. For actionable modelling, incorporate census cohort projections, Social Security actuarial reports and insurer longevity tables as core inputs.

Sector Implications

Healthcare and pharmaceuticals are the most direct beneficiaries of an older population. Longer lives mean extended demand for chronic disease management, elective procedures and long-term care. Companies such as UnitedHealth Group (UNH) and Johnson & Johnson (JNJ) are natural touchpoints for investors assessing exposure to increasing eldercare expenditure: payors will face higher utilization, while device and pharma companies may see elongated product lifecycles tied to chronic therapies.

Financial services and asset managers will also feel pressure to redesign retirement products. Defined-benefit plans have largely been replaced by DC plans; longer lifespans increase the risk of outliving savings. This dynamic favors longevity hedging solutions, annuity wrappers, and products that blend liquid and illiquid income streams. Institutional pensions will need to revisit discount rate assumptions and funding strategies; sovereigns must model pension obligations under extended-longevity scenarios and stress test on 2034 demographic milestones.

Real estate and consumer sectors will diverge by subsegment. Demand for walkable, single-floor housing and assisted living capacity is likely to grow, supporting specialized REITs and developers focused on senior housing. Conversely, discretionary sectors skewed to younger demographics could face slower growth. Investors should compare revenue growth and margin resilience of companies with significant exposure to older consumers against S&P 500 benchmarks (SPX) and peer groups to isolate secular winners.

Risk Assessment

Policy risk is a principal macro variable. If longevity gains outpace fiscal adjustment, governments may respond with tax reforms, pension means-testing, or entitlement restructuring—each carrying market implications. For U.S. federal finances, the combination of increased entitlement outlays and slower worker growth raises debt-to-GDP trajectories unless offset by higher revenues or spending restraint. Scenario analysis should incorporate potential tax-rate paths and benefit reform triggers tied to dependency thresholds.

Operational risks for corporations include workforce planning and productivity. A multi-decade working life implies employers will manage multi-generational careers, with implications for training investment, job design and automation. Firms that fail to adapt could face higher turnover, skills mismatches and compensation inflation for older-worker-friendly roles. Labor force participation metrics and BLS cohort analyses should be monitored quarterly to detect inflection points in older-worker engagement and retirement timing.

Market risks extend to asset valuations. If investors discount future cash flows using assumptions that understate longevity-driven cost growth, price corrections could be abrupt when actuarial realities are priced in. Fixed-income markets, in particular, will re-rate long-duration liabilities if pension sponsors revise discount rates or if sovereign yields move to reflect higher long-run fiscal risks. Liquidity in longevity-hedging instruments will be a second-order risk for funds needing to rebalance quickly.

Fazen Markets Perspective

Fazen Markets sees a high probability that markets will underappreciate the heterogeneity of longevity outcomes, producing mispriced sector exposures. Our contrarian view is that longevity is not uniformly positive for healthcare equities; margins will be squeezed for providers operating in fee-for-service environments without parallel productivity gains. Investors should differentiate between companies positioned to capture chronic-care demand with scalable models and those exposed to cost inflation in labor-intensive care settings.

We also note a counterintuitive outcome: longer working lives can compress near-term consumer spending for certain cohorts as households shift from consumption to precautionary saving to fund extended retirement horizons. That could create a multi-year headwind for discretionary sectors even as healthcare and housing benefit. Our scenario work models a 5-10% reallocation of household spending from discretionary travel and leisure into healthcare and home services for cohorts aged 50-74 by 2040.

Finally, from a policy-arbitrage perspective, states and municipalities with flexible retirement policies, higher migration inflows and younger median ages will outperform on tax-base resilience. Investors can use state-level demographic differentials as an overlay when selecting municipal bonds or real-estate-backed exposures. See our broader commentary on demographic overlays at topic and related portfolio implementation notes at topic.

Outlook

Over the next decade, investors should expect a reallocation of capital toward scalable healthcare delivery, longevity risk-transfer instruments, and senior housing. By 2034—the Census milestone—market participants who have not stress-tested portfolios to account for elevated centroid longevity will face valuation and solvency surprises. Active managers will find alpha in nuanced secular plays: targeted med-tech, managed-care operators with risk-bearing capabilities, and innovative annuity providers.

Medium-term indicators to watch include participation rates for workers aged 55-74, annualized growth in centenarian population counts (as reported by the SSA and CDC), and state-level dependency ratio shifts. These metrics provide leading signals on when demand shifts translate into revenue and cost trends for companies. For sovereign and corporate balance-sheet stress tests, run scenarios that assume a 10-20% upward revision in longevity probabilities over baseline and measure sensitivity of liabilities and cash flows.

Tactically, diversify across real assets with embedded inflation protection and select equities with durable cash flows tied to elder demand. Maintain liquidity to exploit dislocations when policy pivots occur—pension funding reforms or entitlement negotiations are likely to produce episodic market volatility. Fazen Markets will update our model assumptions as new actuarial and census releases appear and publish scenario matrices for institutional clients on request.

FAQ

Q: How likely is it that an individual born in 2026 will reach age 100?

A: Estimates vary by source and are sensitive to socioeconomic status and health trends; MarketWatch (May 9, 2026) aggregates actuarial studies that place the probability materially higher than historical levels, with some studies for developed economies suggesting probabilities in the tens of percent. Historical precedents show that population-level centenarian counts rise nonlinearly as mortality at older ages improves; however, individual outcomes depend on cohort-specific health, income and geography.

Q: What are the immediate signals investors should track to validate a longer-working-life thesis?

A: Track labor-force participation rates for ages 55-74 published monthly by the BLS, median retirement ages in Social Security claiming data (SSA annual reports), and private-sector surveys on phased retirement adoption. Also monitor corporate guidance on workforce training spend and HR policies; increases in employer-subsidized retraining or flexible schedules are leading indicators that firms expect longer careers.

Q: Can longevity gains be offset by rising morbidity or healthcare inflation?

A: Yes. Longer lifespans with poorer health quality (higher morbidity) raise per-capita healthcare costs more than longevity alone. Monitor disability-adjusted life year (DALY) trends and chronic disease prevalence from CDC reports; diverging morbidity trends would disproportionately raise utilization and cost inflation for payors and providers.

Bottom Line

Longer lives and an ageing U.S. population are structural forces that will reprice fiscal risk, tilt sector growth toward healthcare and longevity services, and require active scenario planning for pensions and corporate labour strategy. Institutional investors should treat 2034 and the rising centenarian probabilities reported in MarketWatch (May 9, 2026) as planning horizons, not distant hypotheticals.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.